Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 4 Option exercise CFO and Chief Business Officer acquired 50,000 shares (option exercise)
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. 8-K Event Other events
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 8-K Event Regulation FD disclosure
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations · Executive or director change
  11. 8-K Event Regulation FD disclosure
  12. EFFECT Other Notice of Effectiveness
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. UPLOAD Other SEC-generated Letter
  15. S-3 Offering Registration Statement
  16. 4 Derivatives Options or other derivatives
  17. 8-K Event Shareholder vote results
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 19 · 365 filings